Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q60357515)
Watch
English
Hormonal therapy of breast cancer
scientific article published on 01 June 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Hormonal therapy of breast cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
main subject
breast cancer
1 reference
based on heuristic
inferred from title
author name string
G Y Locker
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
publication date
1 June 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
published in
Cancer Treatment Reviews
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
volume
24
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
page(s)
221-240
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
cites work
Advanced breast cancer - additive hormonal therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormonal treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oophorectomy/adrenalectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transsphenoidal hypophysectomy in breast cancer.Evidence for an individual role of pituitary and gonadal hormones in supporting tumor growth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrinologically incomplete transethmoidal trans-sphenoidal hypophysectomy with relief of bone pain in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Corticosteroids for elderly patients with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Functional domains of the human estrogen receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The human estrogen receptor has two independent nonacidic transcriptional activation functions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormone dependency of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The value of estrogen and progesterone receptors in the treatment of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Age-related difference in tamoxifen disposition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oestrogen-responsive human breast cancer in long term tissue culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms of action of endocrine treatment in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new interpretation of antiestrogen action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Possible mechanisms in the emergence of tamoxifen-resistant breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone sulfate to estradiol in the MCF-7 mammary cancer cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation and role of TGF beta production in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms of hormone resistance in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How do breast cancers become hormone resistant?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple splicing variants of the estrogen receptor are present in individual human breast tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of tamoxifen for breast cancer: twenty-eight years later
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen in premenopausal patients with metastatic breast cancer: a review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen rechallenge: response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant Tamoxifen for male breast cancer (MBC)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Locally advanced breast cancer: early results of a randomised trial of multimodal therapy versus initial hormone therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weight gain after primary surgery for breast cancer--effect of tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen-induced hypercalcemia in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormone-induced tumor flare
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen-associated eye disease. A review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coronary heart disease mortality and adjuvant tamoxifen therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential role of tamoxifen in prevention of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of toremifene in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical potential of new antiestrogens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploration of the therapeutic potential of the antiestrogen RU 58668 in breast cancer treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gonadotropin-releasing hormone binding sites in human breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of goserelin for patients with postmenopausal metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibitor development for treatment of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibition for breast cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First generation aromatase inhibitors--aminoglutethimide and testololactone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second generation aromatase inhibitor--4-hydroxyandrostenedione
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progestin therapy of breast cancer: comparison of agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Megestrol acetate versus aminoglutethimide for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Aust
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New endocrine therapies for breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen receptors: new perspectives in breast cancer management.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990051-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0305-7372(98)90051-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
PubMed publication ID
9767736
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9767736
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9767736%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit